Documents: E/CN.7/2016/2-E/CN.15/2016/2 E/CN.7/2016/4 E/CN.7/2016/5 E/CN.7/2016/6 E/CN.7/2016/7 E/CN.7/2016/8 E/CN.7/2016/11 E/CN.7/2016/13 E/CN.7/2016/14 E/CN.7/2016/CRP.3 (a) Demand reduction and related measures; Aldo Lale-Demoz, UNODC: Let me testify to members states the achievements that are available to us. Let me show how I have made notable achievements. The rationale for including health care and treatments are provable. We must move …
United Nations Office on Drugs and Crime (UNODC)
Side event: The nexus between illicit drug cultivation and deforestation and land degradation
Side event organised by the UNODC Studies and Threat Analysis Section and Deutsche Gesellschaft für Internationale Zusammenarbeit. Chair: Several SDGs are about environmental sustainability, so this issue is very important. SDG 15, in particular, is most relevant to today’s discussion. The cultivation and production of narcotic drugs touches on the issue of environmental sustainability. GIZ and …
Side event: Roads to Recovery – Quality Standards for the Treatment of Drug Use Disorders
Gilberto Gerra, UNODC, Chair: thanks board, floor and CSTF. Roads to recovery are different and varied. Each person has a unique history and needs a personalized response. Equally important is to recover good health, dignity, interpersonal relationships. No one can recover without community. This is key. Mr. Yuri Fedeltov, UNODC: For several years the UNODC …
Special event – Alternatives to imprisonment and proportionate responses to drug offences
Yury Fedotov, UNODC. My special thanks to Member States, civil society and UN partners in organizing this important event. I also welcome the many distinguished speakers who are with us today. In the discussions leading to next month’s General Assembly special session on the world drug problem, we have seen a growing emphasis on the …
Side Event: Harm reduction and the UNGASS: Feedback from the Expert Group Meeting in Berlin
Side event organised by Germany, GIZ and the International Drug Policy Consortium The Conference Room paper is available here. Marlene Mortler MP, Drug Commissioner of the Federal Government of Germany. On behalf of the German delegation at CND, I am delighted to welcome all of you to this important event, and I would like to thank …
Side Event: Resolving the Global Crisis of Untreated Pain by Improving Access to Controlled Medicines within the Framework of the SDGs
Marie-Paule Kieny, WHO: Emphasize that access to essential medicines is a fundamental pillar. Not nearly enough focus has been paid to access to essential medicines. One of the most important medicines, morphine, is emblematic of the fight to ensure access of medicines. Considered the gold standard for pain relief, yet more than 5 billion people …